TRPV3 promotes angiogenesis in non-small-cell lung cancer (NSCLC) through the HIF-1α/VEGF pathway [163], while TRPV4 modulates mechanosensitivity in tumor endothelial cells to regulate vascular maturation [164]. Here, VEGFA is linked to non-small cell lung carcinoma.